Group sales increasing by more than a fifth to €462.9m ($507m), as demand soared following the coronavirus outbreak, combined with a handle on costs led [Krka] to report earnings before interest and tax that were 85% higher at €133.9m in the first three months of this year.
Krka’s expenses during the quarter comprised only a small increase in research and development spending, up 3% to €37.6m, as...







